Results 1 to 10 of about 515,262 (372)
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Nature, 2015Samir Bhatt+2 more
exaly +2 more sources
The global distribution of clinical episodes of Plasmodium falciparum malaria
Nature, 2005Robert W Snow, Simon I Hay
exaly +2 more sources
Windborne long-distance migration of malaria mosquitoes in the Sahel
Nature, 2019Diana L Huestis, V Nikolaenko, Y Noguchi
exaly +2 more sources
Malaria Journal, 2021
Background Remaining Plasmodium falciparum cases in Cambodia are concentrated in forested border areas and in remote populations who are hard to reach through passive case detection.
Ann-Sophie Stratil+9 more
doaj +1 more source
Background Remaining Plasmodium falciparum cases in Cambodia are concentrated in forested border areas and in remote populations who are hard to reach through passive case detection.
Ann-Sophie Stratil+9 more
doaj +1 more source
Malaria Journal, 2023
Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in ...
Anthony Nuwa+20 more
doaj +1 more source
Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in ...
Anthony Nuwa+20 more
doaj +1 more source
Bulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi+11 more
doaj +1 more source
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi+11 more
doaj +1 more source
Malaria Journal, 2023
Background Seasonal malaria chemoprevention (SMC) is a safe and effective intervention for preventing malaria in children under 5 years of age. Lead mothers are community health volunteers that help caregivers comply with monthly administration of anti ...
Ekechi Okereke+15 more
doaj +1 more source
Background Seasonal malaria chemoprevention (SMC) is a safe and effective intervention for preventing malaria in children under 5 years of age. Lead mothers are community health volunteers that help caregivers comply with monthly administration of anti ...
Ekechi Okereke+15 more
doaj +1 more source
Malaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye+6 more
doaj +1 more source
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye+6 more
doaj +1 more source
Artemisinin resistance in Plasmodium falciparum malaria.
New England Journal of Medicine, 2009BACKGROUND Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease.
A. Dondorp+22 more
semanticscholar +1 more source
BMC Health Services Research, 2022
Background Bi-annual high dose vitamin A supplements administered to children aged 6–59 months can significantly reduce child mortality, but vitamin A supplementation (VAS) coverage is low in Nigeria.
Olusola Oresanya+15 more
doaj +1 more source
Background Bi-annual high dose vitamin A supplements administered to children aged 6–59 months can significantly reduce child mortality, but vitamin A supplementation (VAS) coverage is low in Nigeria.
Olusola Oresanya+15 more
doaj +1 more source